Skip to content

Expression of Human beta-defensins in Mycoplasm Pneumoniae Pneumonia and Relationship Between beta-defensins and Prognosis in patients with Mycoplasm Pneumoniae Pneumonia

Expression of Human beta-defensins in Mycoplasm Pneumoniae Pneumonia and Relationship Between beta-defensins and Prognosis in patients with Mycoplasm Pneumoniae Pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010902
Enrollment
Unknown
Registered
2017-03-17
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

CAP:blood collection
CAP:throat swab collection
health group:blood collection

Sponsors

Department of Respiratory Medicine Beijing Friendship Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. CAP group Inclusion criteria: patients who diagnosed as CAP according to CAP guideline(2016 edition) designed by Respiratory Society of Chinese Medical Association. Age 16 years or older; 2. Health group: Inclusion criteria: Aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1. CAP group: Exclusion criteria: Hospital acquired or healthcare acquired pneumonia; Pregnancy; Malignancy; Conditions likely to cause diagnostic confusion or where chest radiograph changes are equivocal (eg, pulmonary fibrosis, suspected active tuberculosis, Churg-Strauss syndrome, allergic bronchopulmonary aspergillosis); Immunosuppression (iatrogenic or acquired); Solid organ transplant; Hematological disorders, including hematological malignancy; Prolonged bed rest or clinical manifestations of aspiration; Acute comorbidities that would make pneumonia severity assessment inappropriate (eg, acute pulmonary embolism); Patients for whom active treatment is not appropriate (palliative care). 2. Health group: Exclusion criteria: Comorbidities including circulation disease, respiratory disease, digestive disease, autoimmune disease and endocrinium disease; Use of glucocorticoid; Mental diseases or other conditions that cannot cooperate with investigators.

Design outcomes

Primary

MeasureTime frame
concentration;concentration;

Countries

China

Contacts

Public ContactXu Bo

Beijing Friendship Hospital Capital Medical University

xubo-ally@hotmail.com+86 13601390345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026